Farnesylthiosalicylic Acid Through Inhibition of Galectin‐3 Improves Neuroinflammation in Alzheimer Disease via Multiple Pathways

Qing Qiu,Cui Li,Xiaoli Zhao,Mengting Yang,Shushu Ding,Haiying Liang,Tingting Chen

DOI: https://doi.org/10.1111/cns.70127

2024-11-28

CNS Neuroscience & Therapeutics

Abstract:FTS through inhibiting Gal‐3 reduces the expression of TLR4 and CD14, alleviates Aβ pathology, and downregulates Aβ‐stimulated TLR2, TLR4 and CD14 expression, and thus alleviates neuroinflammation in Aβ1–42 mice. Aims Many factors affect the neuroinflammatory response in patients with Alzheimer disease (AD). Galectin‐3 (Gal‐3) is closely related to microglial activation in the nervous system and can promote the aggregation of cancer cells in tumors. This study aimed to investigate the mechanism by which farnesylthiosalicylic acid (FTS) affects neuroinflammation in Aβ1–42 mice through Gal‐3. Methods We used the Morris water maze, reverse transcription–polymerase chain reaction (RT–PCR), Western blotting, enzyme‐linked immunosorbent assay (ELISA), and immunofluorescence to conduct our study. Results FTS reduced the levels of proinflammatory factors and microglial activation in Aβ1–42 mice. FTS inhibited total and membrane expression levels of Gal‐3 in Aβ1–42 mice, and the anti‐inflammatory effect of FTS was reversed by Gal‐3–adeno‐associated viral (AAV). FTS reduced the expression levels of toll‐like receptors (TLRs), effects that were reversed by Gal‐3‐AAV. Moreover, FTS ameliorated Aβ oligomerization and accumulation in Aβ1–42 mice, effects that were also reversed by Gal‐3‐AAV. FTS, through the inhibition of the Gal‐3–c‐Jun N‐terminal kinase (JNK) pathway, reduced PS1 expression; in addition, inhibition of Gal‐3 increased the Aβ‐degrading enzymes in Aβ1–42 mice. FTS‐induced improvements in cognition in Aβ1–42 mice were reversed by Gal‐3‐AAV. Conclusion FTS may through inhibiting Gal‐3 reduce the expression of TLR4 and CD14 and alleviate Aβ pathology, downregulating Aβ‐stimulated TLR2, TLR4, and CD14 expression, and thus alleviate neuroinflammation in Aβ1–42 mice.

pharmacology & pharmacy,neurosciences